Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d.
In the transaction, Conformis shareholders will receive only $$2.27 per share. The transaction agreement unreasonably limits competing bids for Conformis by imposing a significant penalty if Conformis accepts a superior bid. Conformis insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Conformis’ board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Conformis.